Angelika Stary
Overview
Explore the profile of Angelika Stary including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
205
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lesiak-Markowicz I, Walochnik J, Stary A, Furnkranz U
Int J Mol Sci
. 2023 May;
24(9).
PMID: 37175701
In , two genes ( and ) have been found to be associated with the invasion of the amniotic cavity, and a single gene () to be associated with intra-amniotic...
2.
Hoxha I, Lesiak-Markowicz I, Walochnik J, Stary A, Furnkranz U
Microorganisms
. 2023 Apr;
11(4).
PMID: 37110356
causes trichomoniasis, the most recurrent sexually transmitted infection (STI) worldwide. Genital mycoplasmas, not considered STI agents, are frequently isolated from the female genital tract. A symbiosis between species and has...
3.
Lesiak-Markowicz I, Walochnik J, Stary A, Furnkranz U
Int J Mol Sci
. 2022 Oct;
23(20).
PMID: 36293276
(TV) is the causative agent of trichomoniasis, the most common nonviral sexually transmitted disease. TV can carry symbionts such as virus (TVV) or . Four distinct strains of TV are...
4.
Stary A
Acta Derm Venereol
. 2020 Mar;
100(9):adv00114.
PMID: 32207537
As long as 400 years ago, syphilitic ulcers and gonococcal discharge were observed in connection with sexual intercourse. War, poverty, and lack of efficient therapeutic options led to a high...
5.
Cole M, Field N, Pitt R, Amato-Gauci A, Begovac J, French P, et al.
Sex Transm Infect
. 2019 Jun;
96(2):137-142.
PMID: 31235527
Objectives: Understanding the public health impact of lymphogranuloma venereum (LGV) in Europe is hampered by inadequate diagnostics and surveillance systems in many European countries. We developed and piloted LGV surveillance...
6.
Cole M, Quaye N, Jacobsson S, Day M, Fagan E, Ison C, et al.
BMC Infect Dis
. 2019 Mar;
19(1):281.
PMID: 30909883
Background: Confidence in any diagnostic and antimicrobial susceptibility testing data is provided by appropriate and regular quality assurance (QA) procedures. In Europe, the European Gonococcal Antimicrobial Susceptibility Programme (Euro-GASP) has...
7.
Stary A, Heller-Vitouch C
J Dtsch Dermatol Ges
. 2017 Feb;
15(2):241-243.
PMID: 28214317
No abstract available.
8.
9.
Jacobsson S, Golparian D, Cole M, Spiteri G, Martin I, Bergheim T, et al.
J Antimicrob Chemother
. 2016 Jul;
71(11):3109-3116.
PMID: 27432597
Objectives: To elucidate the genome-based epidemiology and phylogenomics of azithromycin-resistant (MIC >2 mg/L) Neisseria gonorrhoeae strains collected in 2009-14 in Europe and clarify the azithromycin resistance mechanisms. Methods: Seventy-five azithromycin-resistant...
10.
Stary A, Heller-Vitouch C, Binder M, Geusau A, Stary G, Rappersberger K, et al.
J Dtsch Dermatol Ges
. 2015 Oct;
13(11):1136-45.
PMID: 26513072
Background And Objectives: The increase in minimum inhibitory concentrations (MICs) of cephalosporins for Neisseria gonorrhoeae has given rise to concerns regarding potentially untreatable gonococcal infections. The goal was to ascertain...